disease (CKD) is an important source of long-term morbidity and mortality. It has been estimated that CKD affects more than 20 million people in the United States. Given that most patients are asymptomatic until the disease has significantly progressed, they remain unaware of the condition. Thus, it is essential to have clinical practice guidelines (BIOMARKERS aimed at early detection, evaluation, diagnosis, and treatment of this condition.
Manuela Bova, L.S. (2017). POTENTIAL NEW GENETIC AND BIOCHEMICAL MARKERS OF CHRONIC KIDNEY FAILURE. In PROCEEDINGS OF THE SYMPOSIUM " UPDATES IN PATHOBIOLOGY : CAUSALITY AND CHANCE IN AGEING, AGE- RELATED DISEASES AND LONGEVITY" (pp. 111-123). Palermo : Edity Società Cooperativa per conto di NDF-Giulia Accardi & Calogero Caruso.
POTENTIAL NEW GENETIC AND BIOCHEMICAL MARKERS OF CHRONIC KIDNEY FAILURE
Manuela Bova;Letizia Scola;Domenico Lio.
2017-01-01
Abstract
disease (CKD) is an important source of long-term morbidity and mortality. It has been estimated that CKD affects more than 20 million people in the United States. Given that most patients are asymptomatic until the disease has significantly progressed, they remain unaware of the condition. Thus, it is essential to have clinical practice guidelines (BIOMARKERS aimed at early detection, evaluation, diagnosis, and treatment of this condition.
| File | Dimensione | Formato | |
|---|---|---|---|
|
proceeding 2017.pdf
Solo gestori archvio
Descrizione: Articolo principale
Dimensione
1.17 MB
Formato
Adobe PDF
|
1.17 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
